KAMPALA – Uganda’s ministry of health on Sunday said it has registered 12 new cases of COVID-19, bringing the total number of infections in the country to 939.
Out of the 2,103 samples from cross-border cargo truck drivers, community and returnees tested over the last 24 hours, two Ugandan truck drivers who came in via Malaba and Mutukula points of entry, 7 contacts from Amuru and three returnees (1 from South Africa and 2 from the Democratic Republic of Congo) tested positive for the virus.
Africa Tembelea has also learnt that 11 more foreign truck drivers who tested positive for COVID-19 at Uganda’s points of entry were handed back to their countries of origin.
According to the ministry of health, a total of 891 patients that include both Ugandans and Foreigners have since been discharged from various hospitals across the country.
Currently, the number of active cases on admission in Uganda stands at 197 out of whom 167 are Ugandans, 25 foreigners and 5 refugees.
Africa Tembelea understands that whereas some foreigners and refugees are admitted in Uganda’s health facilities, they are however NOT captured in the cumulative confirmed COVID-19 cases.
In a related development, the World Health Organization (WHO) said on Saturday that it was stopping its trials of the malaria drug hydroxychloroquine and combination HIV drug lopinavir/ritonavir in hospitalised patients with COVID-19 after they failed to reduce mortality.
The setback came as the WHO also reported more than 200,000 new cases globally of the disease for the first time in a single day.
“These interim trial results show that hydroxychloroquine and lopinavir/ritonavir produce little or no reduction in the mortality of hospitalised COVID-19 patients when compared to standard of care,” the WHO said in a statement, adding that solidarity trial investigators will interrupt the trials with immediate effect.”
Africa Tembelea understands that the, taken on the recommendation of the trial’s international steering committee, does not affect other studies where those drugs are used for non-hospitalised patients or as a prophylaxis.
Mike Ryan, WHO’s top emergencies expert, said on Friday that it would be unwise to predict when a vaccine could be ready. While a vaccine candidate might show its effectiveness by year’s end, the question was how soon it could then be mass-produced, he said.